Determinants of health-related quality of life in pharmacoresistant epilepsy: Results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments: Quality of Life in Pharmacoresistant Epilepsy
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
PURPOSE: To evaluate the relative contribution of demographic and epilepsy-related variables, depressive symptoms, and adverse effects (AEs) of antiepileptic drugs (AEDs) to health-related quality of life (HRQOL) in adults with pharmacoresistant epilepsy. METHODS: Individuals with epilepsy whose seizures failed to respond to at least one AED were enrolled consecutively at 11 tertiary referral centers. HRQOL was assessed by the Quality of Life in Epilepsy Inventory-31 (QOLIE-31), AEs by the Adverse Event Profile (AEP), and depressive symptoms by the Beck Depression Inventory-II (BDI-II). Multivariate linear regression models were used to identify variables associated with QOLIE-31 total score and subscale scores. KEY FINDINGS: Of 933 enrolled individuals aged 16 years or older, 809 (87%) were able to complete the self-assessment instruments and were included in the analysis. Overall, 61% of the variance in QOLIE-31 scores was explained by the final model. The strongest predictors of HRQOL were AEP total scores (β = -0.451, p < 0.001) and BDI-II scores (β = -0.398, p < 0.001). These factors were also the strongest predictors of scores in each of the seven QOLIE-31 subscales. Other predictors of HRQOL were age (β = -0.060, p = 0.008), lack of a driving license (β = -0.053, p = 0.018), pharmacoresistance grade, with higher HRQOL in individuals who had failed only one AED (β = 0.066, p = 0.004), and location of the enrolling center. Epilepsy-related variables (seizure frequency, occurrence of tonic-clonic seizures, age of epilepsy onset, disease duration) and number of AEDs had no significant predictive value on HRQOL. The AEP total score was the strongest negative predictor of HRQOL in the subgroup of 362 patients without depressive symptoms (BDI-II score <10), but even in this subgroup the BDI-II score was retained as a significant predictor. SIGNIFICANCE: In individuals with pharmacoresistant epilepsy, AEs of medication and depressive symptoms are far more important determinants of HRQOL than seizures themselves. When seizure freedom cannot be achieved, addressing depressive comorbidity and reducing the burden of AED toxicity is likely to be far more beneficial than interventions aimed at reducing the frequency of seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Quality of life of people with epilepsy: a European study
Baker, G. A., Jacoby, A., Buck, D., Stalgis, C., & Monnet, D. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01128.x · Cited by 847
Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory
Cramer, J. A., Perrine, K., Devinsky, O., Bryant‐Comstock, L., Meador, K., & Hermann, B. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01278.x · Cited by 782 · cited 1×
“HRQOL was measured by using the validated Italian version of the Quality of Life in Epilepsy Inventory-31 (QOLIE-31) (Beghi et al., 2005), a widely used epilepsyspecific self-administered instrument (Cramer et al., 1998).”
MethodRapid detection of major depression in epilepsy: a multicentre study
Gilliam, F. G., Barry, J. J., Hermann, B. P., Meador, K. J., Vahle, V., & Kanner, A. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70415-x · Cited by 712
Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy
Boylan, L. S., Flint, L. A., Labovitz, D. L., Jackson, S. C., Starner, K., & Devinsky, O. (2004) · Neurology · doi:10.1212/01.wnl.0000103282.62353.85 · Cited by 644
Development of the Quality of Life in Epilepsy Inventory
Devinsky, O., Vickrey, B. G., Cramer, J., Perrine, K., Hermann, B., Meador, K., & Hays, R. D. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb00467.x · Cited by 634 · cited 1×
“…of medication (AEP), and depressive symptoms (BDI-II) have all been shown to be reliable and valid both in their original form (Baker et al., 1994; Devinsky et al., 1995; Beck et al., 1996; Baker et al., 1997) and in the Italian-language version (Beghi et al., 2005; Ghisi et al., 2006; Tozzi et…”
MethodDepression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment
Kanner, A. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00469-4 · Cited by 525
Johnson, E. K., Jones, J. E., Seidenberg, M., & Hermann, B. P. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.47003.x · Cited by 523
Taylor, R. S., Sander, J. W., Taylor, R. J., & Baker, G. A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03213.x · Cited by 393
Determinants of health-related quality of life in Parkinson’s disease: A systematic review
Soh, S.-E., Morris, M. E., & McGinley, J. L. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.08.012 · Cited by 386
Social Functioning, Psychological Functioning, and Quality of Life in Epilepsy
Suurmeijer, T. P. B. M., Reuvekamp, M. F., & Aldenkamp, B. P. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.37000.x · Cited by 364
Systematic screening allows reduction of adverse antiepileptic drug effects: A randomized trial
Gilliam, F. G., Fessler, A. J., Baker, G., Vahle, V., Carter, J., & Attarian, H. (2004) · Neurology · doi:10.1212/wnl.62.1.23 · Cited by 340
Optimizing health outcomes in active epilepsy
Gilliam, F. (2002) · Neurology · doi:10.1212/wnl.58.8_suppl_5.s9 · Cited by 334
The pharmacological treatment of epilepsy in adults
Perucca, E., & Tomson, T. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70047-3 · Cited by 334
Self-citationDepression and Cardiac Disease: A Review
Celano, C. M., & Huffman, J. C. (2011) · Cardiology in Review · doi:10.1097/crd.0b013e31820e8106 · Cited by 320
The Relationship of Neuropsychological Functioning to Quality of Life in Epilepsy
Perrine, K., Hermann, B. P., Meador, K. J., Vickrey, B. G., Cramer, J. A., Hays, R. D., & Devinsky, O. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540340089017 · Cited by 319
Quantifying the response to antiepileptic drugs: Effect of past treatment history
Schiller, Y., & Najjar, Y. (2008) · Neurology · doi:10.1212/01.wnl.0000286959.22040.6e · Cited by 313
Seizure frequency and the health-related quality of life of adults with epilepsy
Leidy, N. K., Elixhauser, A., Vickrey, B., Means, E., & Willian, M. K. (1999) · Neurology · doi:10.1212/wnl.53.1.162 · Cited by 303
Determinants of quality of life in epilepsy
Loring, D. W., Meador, K. J., & Lee, G. P. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.08.019 · Cited by 260
Adverse antiepileptic drug effects: Toward a clinically and neurobiologically relevant taxonomy
Perucca, P., Carter, J., Vahle, V., & Gilliam, F. G. (2009) · Neurology · doi:10.1212/01.wnl.0000345667.45642.61 · Cited by 237
Ioanna, T., Kocks, J., Tzanakis, N., Siafakas, N., & van der Molen, T. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00029 · Cited by 231
Defining and Measuring Functional Recovery from Depression
Greer, T. L., Kurian, B. T., & Trivedi, M. H. (2010) · CNS Drugs · doi:10.2165/11530230-000000000-00000 · Cited by 222
Psychiatric comorbidity, health, and function in epilepsy
Gilliam, F., Hecimovic, H., & Sheline, Y. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.10.003 · Cited by 222
Quality-of-life trajectories in epilepsy: A review of the literature
Jacoby, A., & Baker, G. A. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.11.013 · Cited by 211
Depression in Epilepsy: Ignoring Clinical Expression of Neuronal Network Dysfunction?
Gilliam, F. G., Santos, J., Vahle, V., Carter, J., Brown, K., & Hecimovic, H. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.452005.x · Cited by 210
Lehrner, J., Kalchmayr, R., Serles, W., Olbrich, A., Pataraia, E., Aull, S., Bacher, J., Leutmezer, F., Gröppel, G., Deecke, L., et al. (1999) · Seizure · doi:10.1053/seiz.1999.0272 · Cited by 206
The association of mood with quality of life ratings in epilepsy
Tracy, J. I., Dechant, V., Sperling, M. R., Cho, R., & Glosser, D. (2007) · Neurology · doi:10.1212/01.wnl.0000242582.83632.73 · Cited by 203
Canevini, M. P., De Sarro, G., Galimberti, C. A., Gatti, G., Licchetta, L., Malerba, A., Muscas, G., La Neve, A., Striano, P., Perucca, E., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02520.x · Cited by 192
Self-citationKanner, A. M., Barry, J. J., Gilliam, F., Hermann, B., & Meador, K. J. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02582.x · Cited by 182
Kwan, P., Yu, E., Leung, H., Leon, T., & Mychaskiw, M. A. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01938.x · Cited by 176
The neuropsychiatry of multiple sclerosis: Focus on disorders of mood, affect and behaviour
Paparrigopoulos, T., Ferentinos, P., Kouzoupis, A., Koutsis, G., & Papadimitriou, G. N. (2010) · International Review of Psychiatry · doi:10.3109/09540261003589323 · Cited by 174
Vickrey, B. G., Hays, R. D., Rausch, R., Sutherling, W. W., Engel, J., & Brook, R. H. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02480.x · Cited by 160
Roy, T., Lloyd, C. E., Pouwer, F., Holt, R. I. G., & Sartorius, N. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03401.x · Cited by 158
Quality of Life in Psychogenic Nonepileptic Seizures
Szaflarski, J. P., Hughes, C., Szaflarski, M., Ficker, D. M., Cahill, W. T., Li, M., & Privitera, M. D. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.35302.x · Cited by 146
Whatley, A. D., DiIorio, C. K., & Yeager, K. A. (2010) · Health Education Research · doi:10.1093/her/cyq001 · Cited by 130
Adverse antiepileptic drug effects in new-onset seizures: A case-control study
Perucca, P., Jacoby, A., Marson, A. G., Baker, G. A., Lane, S., Benn, E. K. T., Thurman, D. J., Hauser, W. A., Gilliam, F. G., & Hesdorffer, D. C. (2011) · Neurology · doi:10.1212/wnl.0b013e318207b073 · Cited by 120
Şenol, V., Soyuer, F. T., Arman, F., & Öztürk, A. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.08.006 · Cited by 115
The Liverpool Adverse Events Profile: Relation to AED Use and Mood
Panelli, R. J., Kilpatrick, C., Moore, S. M., Matkovic, Z., D'Souza, W. J., & O'Brien, T. J. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2006.00956.x · Cited by 115
Health Status of People with Epilepsy Compared with a General Reference Population
Stavem, K., Loge, J. H., & Kaasa, S. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01510.x · Cited by 111
Stigma, seizure frequency and quality of life: The impact of epilepsy in late adulthood
McLaughlin, D., Pachana, N. A., & McFarland, K. A. (2007) · Seizure · doi:10.1016/j.seizure.2007.09.001 · Cited by 110
Pharmacoresistance in Epilepsy
Perucca, E. (1998) · CNS Drugs · doi:10.2165/00023210-199810030-00002 · Cited by 101
Self-citationSzaflarski, M., Meckler, J. M., Privitera, M., & Szaflarski, J. P. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.01.001 · Cited by 94
Depression and end-of-life care for patients with cancer
Rosenstein, D. L. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/drosenstein · Cited by 92
Edefonti, V. C., Bravi, F., Turner, K., Beghi, E., Canevini, M. P., Ferraroni, M., & Piazzini, A. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-33 · Cited by 81
Self-citationPark, S.-P., Song, H. S., Hwang, Y., Lee, H.-W., Suh, C.-K., & Kwon, S. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.05.021 · Cited by 75
Kwon, O., & Park, S.-P. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.01.010 · Cited by 46
Beghi, E., Niero, M., & Roncolato, M. (2005) · Seizure · doi:10.1016/j.seizure.2005.07.008 · Cited by 46
Psychiatric uses of antiepileptic treatments
Boylan, L. S., Devinsky, O., Barry, J. J., & Ketter, T. A. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5069(02)00501-7 · Cited by 43
Assessment of tolerability in elderly patients: Changing to lamotrigine therapy
Evans, B. K., Kustra, R. P., & Hammer, A. E. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.06.001 · Cited by 13
Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen
Kustra, R. P., Meador, K. J., Evans, B. K., Leschek-Gelman, L. M., Groenke, D. A., Hammer, A. E., Nanry, K. P., & Messenheimer, J. A. (2005) · Seizure · doi:10.1016/j.seizure.2005.02.003 · Cited by 11
Cited by
Adverse effects of antiepileptic drugs
Perucca, P., & Gilliam, F. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70153-9 · Cited by 694
Perucca, E., Perucca, P., White, H. S., & Wirrell, E. C. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00151-5 · Cited by 305
Self-citationDepression and Anxiety in People with Epilepsy
Kwon, O.-Y., & Park, S.-P. (2014) · Journal of Clinical Neurology · doi:10.3988/jcn.2014.10.3.175 · Cited by 294
Micoulaud-Franchi, J.-A., Lagarde, S., Barkate, G., Dufournet, B., Besancon, C., Trébuchon-Da Fonseca, A., Gavaret, M., Bartolomei, F., Bonini, F., & McGonigal, A. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.02.015 · Cited by 251
Neurobehavioral comorbidities of epilepsy: Role of inflammation
Mazarati, A. M., Lewis, M. L., & Pittman, Q. J. (2017) · Epilepsia · doi:10.1111/epi.13786 · Cited by 96
Metadata
- Authors
- Luoni, C., Bisulli, F., Canevini, M. P., De Sarro, G., Fattore, C., Galimberti, C. A., Gatti, G., La Neve, A., Muscas, G., Specchio, L. M., Striano, S., Perucca, E., & on behalf of the SOPHIE Study Group
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2011-12
- Volume
- 52
- Issue
- 12
- Pages
- 2181-2191
- ISSN
- 0013-9580 (ISSN-L)
- OpenAlex
- W1482261919
- Cited by
- 287
- References
- 50
- FWCI
- 11.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.